Edoardo Cignoli : A Low Bar for Some New Antibiotics

The FDA's efforts to speed approvals of drugs to fight antibiotic-resistant bacteria will be front and center Monday as the agency considers two new antibiotics with possible advantages.



via WSJ.com: US Business http://ift.tt/1ogyqNH